Ascelia Pharma; Some takeaways from the investor update ahead of the US launch - Redeye

Ascelia is preparing and planning for the launch, and the activities are now expected to shift gear as the pivotal SPARKLE study is fully recruited.

Länk till analysen i sin helhet: https://www.redeye.se/research/889780/ascelia-pharma-some-takeaways-from-the-investor-update-ahead-of-the-us-launch?utm_source=finwire&utm_medium=RSS